Yunhee Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yunhee Kim has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Kunyoo Shin
Institute of Molecular Biology and Genetics, Seoul National University, Seoul, Republic of Korea
3 shared publications Eunjee Kim
Institute of Molecular Biology and Genetics, Seoul National University, Seoul, Republic of Korea
2 shared publications- Inha Kim
Institute of Molecular Biology and Genetics, Seoul National University, Seoul, Republic of Korea
2 shared publications - Juhee Lee
Institute of Molecular Biology and Genetics, Seoul National University, Seoul, Republic of Korea
2 shared publications - Bahram Javidi
University of Connecticut
1 shared publication - Byoungho Lee
Inter-University Semiconductor Research Center, Department of Electrical and Computer Engineering, Seoul National University, 1 Gwanakro, Gwanak-Gu, Seoul 08826, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in Nature
- p. 1-11
Tumour assembloids recapitulate tumour–CAF–T cell crosstalk in renal cancer
Dynamic interactions between tumours and their microenvironment are crucial for cancer progression and therapeutic outcomes 1,2 . However, our understanding of these relationships remains limited by the constrained capacity of current human model systems to manipulate diverse cellular components and to interrogate complex tumour–stroma crosstalk. Here we generated combinatorial, mix-and-match tumour assembloids by conditionally reconstituting multiple components of human renal cell carcinoma, including cancer cells, cancer-associated fibroblasts (CAFs) and tumour-infiltrating immune cells. Using genetically engineered renal cell carcinoma assembloids with humanized mouse models, we uncovered mechanisms by which CAFs coordinate interactions between tumour cells and CD8 + T cells to maintain non-cell-autonomous CD8 + T cell stemness and drive responsiveness to anti-PD-1 therapy. These interactions operate through a tumour–CAF–T cell signalling axis in which tumour-derived WNT induces CAF expression of activin A, which enhances CD8 + T cell stemness and sensitivity to PD-1 blockade. In non-responders, we also identified a subset of WNT-unresponsive CAFs that do not produce activin A, which leads to impaired CD8 + T cell stemness and resistance to therapy. Together, these findings establish a tumour–CAF–T cell axis as a key determinant of heterogeneous responses to immune checkpoint inhibitors. Moreover, tumour assembloids provide a versatile platform for mechanistic dissection of the tumour microenvironment and evaluation of personalized immunotherapy strategies.
- 28 October 2026
- Published by Springer Nature in Nature
- p. 1-11
Open AccessTumour assembloids recapitulate tumour–CAF–T cell crosstalk in renal cancer
Dynamic interactions between tumours and their microenvironment are crucial for cancer progression and therapeutic outcomes 1,2 . However, our understanding of these relationships remains limited by the constrained capacity of current human model systems to manipulate diverse cellular components and to interrogate complex tumour–stroma crosstalk. Here we generated combinatorial, mix-and-match tumour assembloids by conditionally reconstituting multiple components of human renal cell carcinoma, including cancer cells, cancer-associated fibroblasts (CAFs) and tumour-infiltrating immune cells. Using genetically engineered renal cell carcinoma assembloids with humanized mouse models, we uncovered mechanisms by which CAFs coordinate interactions between tumour cells and CD8 + T cells to maintain non-cell-autonomous CD8 + T cell stemness and drive responsiveness to anti-PD-1 therapy. These interactions operate through a tumour–CAF–T cell signalling axis in which tumour-derived WNT induces CAF expression of activin A, which enhances CD8 + T cell stemness and sensitivity to PD-1 blockade. In non-responders, we also identified a subset of WNT-unresponsive CAFs that do not produce activin A, which leads to impaired CD8 + T cell stemness and resistance to therapy. Together, these findings establish a tumour–CAF–T cell axis as a key determinant of heterogeneous responses to immune checkpoint inhibitors. Moreover, tumour assembloids provide a versatile platform for mechanistic dissection of the tumour microenvironment and evaluation of personalized immunotherapy strategies.
- Open Access
- 25 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1)
Single rosette-based generation of uniform cortical assembloids recapitulating cellular interactions between neurons and glial cells
Despite recent advances, current brain organoid technologies face ongoing challenges in managing heterogeneity and representing the diverse structure and cell types of the human brain. Here, we develop a module-based cellular reconstitution technology to sequentially build uniform cortical assembloids with mature cortical structures and functional connectivity. The uniformity and maturity of the cortical assembloids are achieved by creating single-rosette-based organoids at the early stage, whose sizes were big and consistent with the treatment of Wnt and Hedgehog agonists, followed by spatial reconstitution with the Reelin-expressing neuronal layer and non-neuronal glial cells. The resulting single-rosette-based cortical assembloids are highly uniform and reproducible without significant batch effects, solving major heterogeneity issues caused by difficulties in controlling the number and size of rosettes in conventional multi-rosette organoids. Furthermore, these cortical assembloids structurally and functionally recapitulate the physiology of the human brain, including the six-layered cortical structure, functional connectivity, and dynamic cellular interplay between neurons and glial cells. Our study thus provides an innovative preclinical model to study a range of neurological disorders, understanding the pathogenesis of which requires an organoid system capable of representing the dynamic cellular interactions and the maturity of the human brain.
- 25 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1)
Open AccessSingle rosette-based generation of uniform cortical assembloids recapitulating cellular interactions between neurons and glial cells
Despite recent advances, current brain organoid technologies face ongoing challenges in managing heterogeneity and representing the diverse structure and cell types of the human brain. Here, we develop a module-based cellular reconstitution technology to sequentially build uniform cortical assembloids with mature cortical structures and functional connectivity. The uniformity and maturity of the cortical assembloids are achieved by creating single-rosette-based organoids at the early stage, whose sizes were big and consistent with the treatment of Wnt and Hedgehog agonists, followed by spatial reconstitution with the Reelin-expressing neuronal layer and non-neuronal glial cells. The resulting single-rosette-based cortical assembloids are highly uniform and reproducible without significant batch effects, solving major heterogeneity issues caused by difficulties in controlling the number and size of rosettes in conventional multi-rosette organoids. Furthermore, these cortical assembloids structurally and functionally recapitulate the physiology of the human brain, including the six-layered cortical structure, functional connectivity, and dynamic cellular interplay between neurons and glial cells. Our study thus provides an innovative preclinical model to study a range of neurological disorders, understanding the pathogenesis of which requires an organoid system capable of representing the dynamic cellular interactions and the maturity of the human brain.
- Open Access
- 2 October 2023
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 55 (10) , 2127-2137
A new era of stem cell and developmental biology: from blastoids to synthetic embryos and beyond
Recent discoveries in stem cell and developmental biology have introduced a new era marked by the generation of in vitro models that recapitulate early mammalian development, providing unprecedented opportunities for extensive research in embryogenesis. Here, we present an overview of current techniques that model early mammalian embryogenesis, specifically noting models created from stem cells derived from two significant species:Homo sapiens, for its high relevance, andMus musculus, a historically common and technically advanced model organism. We aim to provide a holistic understanding of these in vitro models by tracing the historical background of the progress made in stem cell biology and discussing the fundamental underlying principles. At each developmental stage, we present corresponding in vitro models that recapitulate the in vivo embryo and further discuss how these models may be used to model diseases. Through a discussion of these models as well as their potential applications and future challenges, we hope to demonstrate how these innovative advances in stem cell research may be further developed to actualize a model to be used in clinical practice.
- 2 October 2023
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 55 (10) , 2127-2137
Open AccessA new era of stem cell and developmental biology: from blastoids to synthetic embryos and beyond
Recent discoveries in stem cell and developmental biology have introduced a new era marked by the generation of in vitro models that recapitulate early mammalian development, providing unprecedented opportunities for extensive research in embryogenesis. Here, we present an overview of current techniques that model early mammalian embryogenesis, specifically noting models created from stem cells derived from two significant species:Homo sapiens, for its high relevance, andMus musculus, a historically common and technically advanced model organism. We aim to provide a holistic understanding of these in vitro models by tracing the historical background of the progress made in stem cell biology and discussing the fundamental underlying principles. At each developmental stage, we present corresponding in vitro models that recapitulate the in vivo embryo and further discuss how these models may be used to model diseases. Through a discussion of these models as well as their potential applications and future challenges, we hope to demonstrate how these innovative advances in stem cell research may be further developed to actualize a model to be used in clinical practice.
- 31 August 2020
- Published by Institute of Agriculture and Life Science, Gyeongsang National University in Journal of Agriculture & Life Science
- Vol. 54 (4) , 1-5
Isolation and Expression Analysis of a WRKY Transcription Factor in Sweet potato
- 31 August 2020
- Published by Institute of Agriculture and Life Science, Gyeongsang National University in Journal of Agriculture & Life Science
- Vol. 54 (4) , 1-5
Isolation and Expression Analysis of a WRKY Transcription Factor in Sweet potato
- 1 October 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in LEOS 2007 - IEEE Lasers and Electro-Optics Society Annual Meeting Conference Proceedings
- No. 10928081,p. 356-357
Resolution-enhanced three-dimensional integral imaging using double display devices
A resolution-enhanced integral imaging using double display devices is proposed in this paper. Two three-dimensional images that express different pixels are combined by a beam splitter.
- 1 October 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in LEOS 2007 - IEEE Lasers and Electro-Optics Society Annual Meeting Conference Proceedings
- No. 10928081,p. 356-357
Resolution-enhanced three-dimensional integral imaging using double display devices
A resolution-enhanced integral imaging using double display devices is proposed in this paper. Two three-dimensional images that express different pixels are combined by a beam splitter.